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Clarification of particle-cellular interactions, in
what Policard called the "conflict of living matter
with the mineral world," (1) has had slow develop-
ment. Even the special potential of crystalline silica
(quartz) was not fully understood until Collis' classic
description of its unique biological properties in his
Milroy lecture of 1915 (2). It was known that some
individuals exposed to dust suffered severe lung
damage (the knife grinders of Sheffield, for exam-
ple). But it was equally known that others exposed
to "dust" had no such consequence. Farm laborers
in England, who worked in clouds of dusts, had the
advantage of long life spans. Evidently, there were
dusts and dusts, reacting differently with tissues.
This was confirmed when Collis observed that
workers exposed to quartz died much more fre-
quently of tuberculosis than those with other kinds
of dust exposure. Even against this background, elu-
cidation of the mechanisms ofsilica's biological prop-
erties is still incomplete; while we have advanced
our knowledge of these particles' intracellular activ-
ity (3), much study is now directed to membrane ef-
fects (4) and the question of immunological mechan-
isms (5).
Problems associated with the activity of fibrous
silicate minerals have remained incompletely ex-
plored, with equal delay. The first patient of whom
we have record in whom asbestos was appreciated
to be a health problem was an asbestos factory
worker seen by H. Montague Murray in 1898 at the
Charing Cross Hospital in London. The man died
the next year of respiratory insufficiency. An au-
topsy showed diffuse pulmonary fibrosis. The death
was commented on in the records of a Depart-
mental Committee of the British Parliament in 1906
(6). There were additional scattered references to
the possibility of asbestos-associated respiratory
disease in the following years (7), but the first docu-
mented case report did not appear in the medical
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literature until 1924 (8, 9). The spectrum of asbestos-
associated disease was extended in the next five de-
cades to include not only asbestosis (parenchymal
and pleural fibrosis) but a number of neoplasms,
with increased incidence of lung cancer, pleural and
peritoneal mesothelioma, cancer of the esophagus,
stomach, colon-rectum, pharynx and buccal cavity,
larynx and kidney (10). Unfortunately, there has
been considerable disparity between the clinical and
pathological observations that have been made, and
our understanding of the mechanisms and cellular
processes related to these observations. It may
therefore be useful to outline some of the critical
questions that characterize this imbalance.
A basic question relates to the problem of inter-
stitial fibrosis. While is has been known for more
than 80 years that this can develop following asbes-
tos exposure, it is still not understood why. For
example, not all individuals who inhale asbestos will
develop fibrosis, and among those who do, it often
develops in different degree, despite equal exposure
and equal tissue residence. In some individuals,
there will be minimal fibrotic reaction; in others, the
changes are much more extensive. Some show most
damage in the parenchyma; others have little inter-
stitial change, but much pleural fibrosis. A number
of explanations have been offered, acting singly or
in combination, ranging from the nature of the fi-
bers [mineral type, length, diameter, surface, crystal
structure, etc. (11)] to individual susceptibility.
While a variety of'mineral dusts will produce paren-
chymal fibrosis, it appears that only asbestos and a
few other materials, viz., zeolites (12), have the ca-
pacity to produce pleural change in the form of lo-
calized or diffuse pleural fibrosis and/or calcification.
It is not that other dusts do not reach the pleura.
Particles of iron oxide instilled into the pleural cav-
ity were shown in experiments more than 50 years
ago to enter the parietal pleura, and black reticula-
tion of the pleura in coal miners is commonplace.
Yet little is so far known concerning cellular reac-
tions of the mesothelial surfaces of the chest (or ofSELIKOFFAND FRANK
the peritoneal cavity!) to help us understand why
both fibrotic and neoplastic disease can occur follow-
ing the inhalation of some fibrous microparticles.
Once more, one is struck by the range from minimal
to extensive disease and, once again, the question of
individual susceptibility must be addressed. Appro-
priate in vitro test systems should prove particu-
larly useful in allowing better understanding of
mesothelial cell response to particulate matter.
In developing such systems, it would be particu-
larly advantageous if the problem of long clinical la-
tency were to be faced. Clinically, this is well known
and well accepted. Radiological evidence of fibrosis/
calcification usually does not begin to appear for 20
years or more following onset of exposure, although
some cases are seen earlier (13). Even though it is
appreciated that histological and even gross ana-
tomical changes may be present before X-ray abnor-
malities, there is still a period of many years before
such alteration is noted. It is also appreciated that
there may be long continued tissue residence of in-
haled fibers, once inhaled. Nevertheless, we do not
understand the cellular-particle interactions that ex-
plain the decades-long continuum of histological de-
velopment. This is equally true with neoplastic
change in the mesothelial surfaces, where mesothe-
lioma generally does not become clinically evident
until 20 to 40 years or more after initial exposure
(14). Better understanding of what is happening at
the cellular level is needed to understand the years-
long progression and development of disease, both
with continuing exposure or following limited,
short-term exposure with subsequent passage of
time and later occurrence of disease (15).
The problem of neoplastic change following asbes-
tos exposure has overtaken that of fibrotic reaction,
and asbestos-associated neoplasms have taken pride
of place in public health concerns related to asbes-
tos exposure (16). Among occupational groups, lung
cancers are the most important asbestos-associated
neoplasms, with mesothelioma following close by.
With lower levels of exposure, as seen in environ-
mental circumstances, mesothelioma has gained
prominence, although we have few data concerning
increased incidence of bronchogenic carcinoma with
such exposure. Lung cancer developing following
exposure to asbestos was first reported by Lynch
and Smith in 1935 in the United States (17), and, in
the same year, the first asbestos-related lung can-
cers were also reported in Great Britain (18). In
1960, Wagner, Sleggs and Marchand emphasized
therelationship between pleural mesothelioma and
asbestos exposure (19). More recently, various other
neoplasms have been found to occur in increased in-
cidence among asbestos-exposed workers (10). Nev-
ertheless, although asbestos reaches virtually every
tissue in the body, only some organs show a neo-
plastic response. Other organs, similarly exposed,
demonstrate no malignant change. For example, A.
M. Langer in our laboratory has demonstrated myr-
iads of asbestos fibers in livers of asbestos workers;
we do not find an increased incidence of primary
hepatocellular carcinoma in cohort studies of asbes-
tos workers (10, 20). There does not seem to be a
statistically significant increased incidence of leuke-
mia or lymphoma, and cancer of the bladder occurs
at about expected levels, despite cancer of the kid-
ney being increased (10). Some tissues do and some
tissues do not react to asbestos with neoplastic
change; study of the cellular reactions to the fiber
might therefore include analysis not only of cellular
neoplastic change in general, but organ differences
as well.
Dose-disease response is ever with us in studying
environmental disease. It is surely true with asbes-
tos. It is now appreciated that significant pulmo-
nary fibrosis is unlikely unless relatively large
amounts of asbestos have been inhaled. Lesser in-
tensities and duration (dose), however, can result in
diffuse interstitial fibrosis of lesser degree. With
even smaller amounts of asbestos, as often obtained
in environmental circumstances (viz., family contact
or neighborhood disease), pleural change alone may
be seen, with very little noted in the lung paren-
chyma. Differences associated with intensity and
duration of exposure also result in differences in rel-
ative frequency of the various asbestos-associated
neoplasms. It is generally agreed that pleural meso-
thelioma can occur with comparatively little asbes-
tos, surely at the levels which occurred in house-
holds of asbestos workers in the past. We do not
know if there is a lower limit of asbestos exposure
that would not be associated with an increased oc-
currence of pleural mesothelioma. Our own experi-
ence indicates that there is dose-disease response
gradient for pleural mesothelioma. It is appreciated
that epidemiological confirmation of such a gradient
at very low levels of exposure (eg., ambient air con-
tamination) will be difficult. In any case, in vitro
stud1ies would be particularly valuableifinformation
could be provided concernirng disease potential at
low levels of exposure. The public health. fmper
tance of such studies is emphasized by observations
of the frequency of asbestos-associated disease
among family contacts of asbestos workers (21). In
one group, approximately one-third of wives and
children developed parenchymaVpleural changes,
and initial observations suggested that approxi-
mately 1% of deaths among family contacts 20
years or more following onset of the workers' em-
ployment were due to pleural mesothelioma. Paren-
thetically, clinical observation suggests that the dif-KEYNOTEADDRESS
ferent mesothelial surfaces respond differently in
terms of dose. Pleural mesothelioma is often a prob-
lem of "low" exposure, in environmental circum-
stances, whereas peritoneal mesothelioma is far
more likely to occur with the heavier exposures of
the work place. Is the cellular response of the pleu-
ral mesothelial cells different than those of the peri-
toneum? Are differences in fiber mass, number, size
responsible, or are there important physiological dif-
ferences (pleural drift, in the lung)?
Clinical and epidemiological observations have
provided another conundrum that can be profitably
explored in in vitro studies-the multiple factor in-
teractions between asbestos exposure and cigarette
smoking. Both, individually, increase the risk of
lung cancer. Nonsmoking asbestors workers have
approximately five times the risk of dying of lung
cancer compared to nonsmokers in general, whereas
those who smoke also have augmentation of their
risk, compared to smokers who are not exposed to
asbestos (22, 23). Thus, it is not a question as to
whether asbestos alone can "cause" lung cancer; it
can. But from a public health point of view this im-
portant potential is not strikingly demonstrated un-
less there is concomitant cigarette smoking. For
nonsmokers, baseline lung cancer risk is generally
low, and even multiplying it five times by the inha-
lation of asbestos still does not result in a very large
number of neoplasms. On the other hand, multiply-
ing the already very high risk of cigarette smokers
results in the extraordinary lung cancer incidence
that we find among asbestos-exposed workers; in
some cohorts, 20% of all deaths are due to this neo-
plasm (20, 23). It appears that similar interaction un-
derlies the increased incidence of cancer of the
esophagus, pharynx and buccal cavity and larynx
(23). On the other hand, there is no such effect for
pleural or peritoneal mesothelioma, cancer of the
stomach or colon-rectum, or kidney cancer. Smoking
and nonsmoking asbestos workers have equal risk.
Two problems therefore need investigation: the na-
ture of the cellular response to the carcinogens,
singly and together, culminating in the neoplastic
change and the nature of differences in cells of dif-
ferent organs in their varying response to the com-
bination of cigarette smoke and asbestos.
Recent observations have added a third problem.
It has been found that asbestos workers who stop
smoking can, within 5 to 10 years, reduce their risk
of dying of lung cancer to approximately one-half or
one-third that of their colleagues who continue to
smoke (24). Thus, while the lung cancers that occur
among asbestos workers who smoke are not rever-
sible once they occur, the risk of developing such
neoplasms can be sharply reduced by cessation of
cigarette smoking. The cellular developments which
underlie such a reversal of risk are unknown, and
their clarification would constitute a major advance.
An overriding question in much of environmental-
ly induced disease is the nature of the interaction
between individual biological constitution (? genetic)
and exogenous agents. This is clearly the case with
asbestos. If we say that 1 in 15 insulation workers
dies of mesothelioma, we are concomitantly saying
that 14 do not. One in five dies of lung cancer, four
escape this fate. Pulmonary asbestosis of sufficient
severity to cause fatal pulmonary insufficiency has
only been seen in approximately 7% of asbestos in-
sulation workers; some, even after 40 years or more
of work in their trade, have normal or virtually nor-
mal chest X-rays (25). The nature and background
for such variations in individual response remain ob-
scure. In our laboratory, with J. G. Bekesi, we have
been investigating occurrence of immunomodifica-
tion associated with asbestos exposure (26). It has
been found, as expected, that virtually all patients
with mesothelioma are markedly immunosup-
pressed. But a few are not, and the curious observa-
tion has been made that those who have survived
more than the usual year or less have been those
with normal or virtually normal immunological sta-
tus. Of course, there is no necessary cause and ef-
fect relationship between these two observations.
Nevertheless, the theoretical connotations seem im-
portant, and we are currently investigating the im-
mune status of a very large number of asbestos in-
sulation and asbestos factory workers, virtually all
of whom are 30 years or more from onset of their
work. Initial investigation of a group of more than
200 men showed lesser or greater degrees of immu-
nosuppression in approximately one-third. We are
particularly interested in the prognostic significance
of variations in the immune state. We consider that
the entire area of variation in immunological status
associated with exposure to asbestos fibers requires
close study at the cellular and serological levels; it is
likely that such studies hold great promise in a very
rapidly developing field.
Our inadequacies concerning basic questions re-
lated to asbestos-associated disease are particularly
disadvantageous at this time. As a result of expo-
sure in the past, much asbestos disease is antici-
pated in the next decades. Nicholson and his col-
leagues have calculated tha-t among workers ex-
posed from 1940-1979 in a number of important
trades and industries (asbestos mining and milling
and factory workers, construction, shipbuilding and
ship repair, chemical plants, refineries, utilities and
power production, transportation, among others)
there will be approximately 9000 excess deaths of
asbestos-associated cancers annually until the turn
of the century, with a lessening incidence thereafter4 SELIKOFFANDFRANK
(27). These projections do not include deaths of as-
bestosis nor deaths of asbestos-associated disease
among family contacts of asbestos workers or
among those exposed in environmental circum-
stances. Nor do they include individuals who suffer
asbestosis, but do not die of this disease. Our ability
to cope with what Doll and Peto have called
". . . this public health disaster" (28) is currently lim-
ited. Better understanding of the basic mechanisms
may allow us to significantly improve management
and treatment of those who have been exposed to
asbestos in the past and who now face an uncertain
future.
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